Clinical experience that mirrors how care actually happens.
From cardiovascular, oncology and rare disease to female health, nutrition and connected devices, we generate evidence across prevention, quality of life and therapy support, with one operating model across every setting.
Built on real studies.
Every area reflects work we have designed, run or supported.
Cross-domain reuse
The same evidence method travels across Rx, CHC, nutrition and devices. The therapeutic question stays constant; the product reality changes.
Patient reality first
We group areas by how patients live them, cardiometabolic, digestive, sexual health, mirroring real care pathways.
Grouped around the patient journey.
Prevention, quality of life and therapy support, seen from the patient's point of view.
Cardiometabolic
From prevention to device-guided management.
- CardiovascularPrevention, hypertension, heart failure, lipid management.
- Metabolic & DiabetesT2D, obesity, metabolic syndrome, glycaemic control.
- EndocrinologyThyroid, adrenal and hormonal disorders.
- NephrologyCKD, dialysis populations, renal-safety programmes.
Oncology & Immunology
Tumor, immune, and vaccine evidence.
- OncologySolid tumours, supportive care, survivorship and quality of life.
- Immunology & AllergologyAutoimmune conditions, atopy, respiratory allergy.
- RheumatologyInflammatory arthritis, autoimmune connective-tissue disease.
- Infectious Diseases & VaccinesVaccine trials, post-market surveillance, RWE.
Digestive Health & Nutrition
Gut, liver, and microbiome science.
Special focus · Probiotic & live-biotherapeutic trials, from claim substantiation to clinical endpoints, in adult and paediatric cohorts.
- GastroenterologyAAD, FAP, gut dysmotility, IBS/IBD, microbiome interventions.
- HepatologyMASLD/NASH, liver-safety endpoints, hepatic function.
- Onco-NutritionNutritional support and cachexia in oncology pathways.
Respiratory & ENT
Airway, allergy, and upper-respiratory endpoints.
- Respiratory & PneumologyAsthma, COPD, cough, upper-airway conditions.
Neuroscience, Mental Health & Behavioural Science
Brain, behaviour, and digital therapeutics.
- Neurology & Cognitive SciencesCognition, neurodegeneration, headache.
- Mental HealthAnxiety, mood, stress-related conditions, digital therapeutics.
- Health Psychology & Behavioural SciencePatient behaviour, adherence, digital behaviour change and the psychological endpoints of chronic care.
- Pain ManagementAcute and chronic pain, musculoskeletal and neuropathic.
- SleepSleep quality, insomnia, sleep-disordered breathing.
Female, Male & Sexual Health
Reproductive, sexual, and urological health.
- Female HealthBacterial vaginosis, VVA, menopause, reproductive health.
- AndrologyMale reproductive and sexual health.
- UrologyLower urinary tract, continence, urological safety.
Skin, Aesthetics & Senses
Dermatology, aesthetics, eye, and oral care.
- Dermatology & CosmeticsAtopic dermatitis, acne, ageing, cosmetic efficacy.
- Aesthetic Medicine & PlasticInjectables, energy-based devices, post-procedure care.
- OphthalmologyDry eye, ocular surface, visual function.
- Oral CareOral hygiene, gingival health, dentifrice and rinse claims.
Musculoskeletal & Paediatrics
Mobility, bone, joint, and paediatric safety.
- Bone & Joint HealthOsteoarthritis, mobility, joint-support interventions.
- PaediatricsInfant nutrition, paediatric safety and tolerability.
Longevity & Healthy Aging
Age-related function and lifespan evidence.
- Longevity & Healthy AgingAge-related function, metabolic health, frailty and lifespan evidence across Pharma, nutrition and devices.
Rare & Ultra-Rare Conditions
Small populations, global reach, RWE-heavy designs.
- Rare DiseasesSmall populations, often heterogeneous, spanning oncology, immunology, neurology and metabolism.
- Ultra-Rare ConditionsSingle-digit incidence programmes, registry and RWE-heavy designs, global reach strategies.
- Orphan & Paediatric Rare DiseasesDevelopmental and inherited conditions, with paediatric extrapolation and family-centred capture.
One therapeutic question, four product realities.
A cardiometabolic or rare-disease hypothesis can run as a Pharma trial, a CHC claim study, a functional-food intervention or a connected-device performance study.
Pharma & Rare Disease
Interventional trials, synthetic-arm designs and RWE for Rx and biotech.
Consumer Health (CHC)
Claim-grade evidence for OTC, supplements and personal care.
Functional Food & Medical Nutrition
Intervention studies for novel food, medical food and functional ingredients.
MedTech & Medical Devices
MDR/IVDR clinical investigations and connected-device performance studies.
From prescription to everyday nutrition, one scientific standard.
Innovative expertise to get where others cannot reach: Rx and biotech, OTC and self-care, medical food and infant nutrition, functional ingredients, personal care, connected and medical devices.
How this depth shows up.
Trial, RWE or scientific survey: choosing the right rigour path before you commit
Two symmetric mistakes cost sponsors the most: assuming a survey will cover everything, or building a full protocol for a question an agile instrument could have answered. The route is decided by the data you intend to capture, not by budget.
ReadHealthy, sub-healthy, diseased: why nutrition and CHC research needs a wider recruiting map
Nutrition and consumer-health studies routinely span three health states, healthy, sub-healthy and diseased, and each needs a different channel. Reaching only one narrows the science.
ReadD-T-P enters the guideline: from pioneer practice to regulatory default
In twenty-four months, direct-to-participant research has moved from 'innovation' to the way GCP is now written. A short reading of the FDA final DCT guidance and ICH E6(R3) with its Annex 2.
ReadTherapeutic fit.
Tell us your indication and product reality, we will show you the relevant experience and the fastest path to evidence.